Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2009 11:01

RNS Number : 2364W
Skyepharma PLC
24 July 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SKYEPHARMA PLC

GB00B3BFNB64

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 N/A

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

N/A 

An event changing the breakdown of voting rights

N/A 

Other (please specify):

N/A 

3. Full name of person(s) subject to the notification obligation:

 UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3.):

 UBS AG LONDON BRANCH

5. Date of the transaction and date on which the threshold is crossed or reached:

 22 JULY 2009

6. Date on which issuer notified:

 24 JULY 2009

7. Threshold(s) that is/are crossed or reached:

 6.07%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

 1,147,010

 1,147,010

 1,452,702

 1,452,702

 -

 6.07%

 -

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,452,702

 6.07%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 ESTEBAN FRANK/ALEXA KOENIG

15. Contact telephone number:

 +41 44 239 5476

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKZLBLKDBZBBD
Date   Source Headline
28th Jan 20167:00 amRNSMundipharma appointed as partner for flutiform
21st Jan 201610:36 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSPre-Close Update
6th Jan 201610:40 amRNSDirector/PDMR Shareholding
23rd Dec 20157:00 amRNSSKP-2076 to be partnered with Mundipharma
21st Dec 20152:47 pmRNSDirector Declaration
15th Dec 20153:36 pmRNSFavourable Resolution with FDA Relating to EXPAREL
14th Dec 201510:47 amRNSHolding(s) in Company
3rd Dec 201510:02 amRNSDirector/PDMR Shareholding
1st Dec 20155:26 pmRNSDirectorate Change
1st Dec 201510:01 amRNSHolding(s) in Company
27th Nov 20153:55 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Update and Capital Markets Meeting
18th Nov 20159:00 amRNSPresents at Jefferies Global Healthcare Conference
4th Nov 201510:52 amRNSDirector/PDMR Shareholding
5th Oct 20159:40 amRNSDirector/PDMR Shareholding
4th Sep 20159:24 amRNSDirector/PDMR Shareholding
1st Sep 201510:29 amRNSHolding(s) in Company
26th Aug 20157:00 amRNS2015 Interim Results
6th Aug 20157:00 amRNSNotice of Results
4th Aug 20153:36 pmRNSDirector/PDMR Shareholding
30th Jul 20152:11 pmRNSHolding(s) in Company
3rd Jul 201510:03 amRNSDirector/PDMR Shareholding
25th Jun 20157:00 amRNSInterim Results Pre-close Trading Update
2nd Jun 20153:03 pmRNSDirector/PDMR Shareholding
1st Jun 20159:00 amRNSPresenting at Jefferies 2015 Healthcare Conference
12th May 20154:26 pmRNSResult of AGM
12th May 20157:00 amRNSAGM Trading Update
11th May 201510:08 amRNSDirector/PDMR Shareholding
24th Apr 201510:27 amRNSDirector Declaration
10th Apr 20154:33 pmRNSAnnual Financial Report
2nd Apr 201512:17 pmRNSDirector/PDMR Shareholding
26th Mar 20154:59 pmRNSDirector/PDMR Shareholding
26th Mar 20154:34 pmRNSDirector/PDMR Shareholding
24th Mar 20157:00 amRNSFinal Results
20th Mar 20159:00 amRNSSkyepharma wins at PLC Awards
11th Mar 20159:49 amRNSHolding(s) in Company
4th Mar 201510:45 amRNSNotice of Results
3rd Mar 20152:58 pmRNSDirector/PDMR Shareholding
25th Feb 20154:14 pmRNSHolding(s) in Company
13th Feb 20157:00 amRNSEarly repayment of the CRC Finance facility
9th Feb 20154:26 pmRNSHolding(s) in Company
3rd Feb 20152:25 pmRNSDirector/PDMR Shareholding
28th Jan 20154:46 pmRNSHolding(s) in Company
14th Jan 20153:46 pmRNSHolding(s) in Company
12th Jan 20157:00 amRNSPre-close update
5th Jan 20155:38 pmRNSDirector/PDMR Shareholding
8th Dec 20142:13 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:33 pmRNSDirector/PDMR Shareholding
1st Dec 20147:04 amRNSKyorin launches flutiform 120-puff version

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.